Olme-Dalcare 40 Tablet
By Olme-Dalcare
Rx
10 Tablet in a Strip

Composition
Olmesartan Medoxomil(40mg)

Manufacturer - Dalmia Healthcare
1307, 1308A, 1308B, 13th Floor, Vikrant Tower – 4, Rajendra Place, New Delhi – 110008 (India)

Expires on or after
April, 2026

liver
Olme-Dalcare 40 Tablet should be used with caution in patients with severe liver disease. It may be necessary to adjust the dosage of Olme-Dalcare 40 Tablet in these cases. It is advised to consult your doctor before using this medication if you have severe liver disease. However, no dose adjustment is recommended for patients with mild liver disease. Please follow your doctor's guidance closely when taking Olme-Dalcare 40 Tablet.

kidney
Caution should be taken when using Olme-Dalcare 40 Tablet in patients with kidney disease. Dosage adjustment may be necessary, so consult your doctor. Regular blood pressure monitoring is advised. Avoid using Olme-Dalcare 40 Tablet in severe kidney disease cases.

alcohol
Olme-Dalcare 40 Tablet can lead to increased drowsiness when taken with alcohol.

driving
Caution should be exercised when driving while taking Olme-Dalcare 40 Tablet, as it might reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Olme-Dalcare 40 Tablet should not be used during pregnancy due to the known risk to the developing baby. In rare life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Always consult your doctor for guidance.

breastfeeding
Olme-Dalcare 40 Tablet should be avoided during breastfeeding as it may pass into breastmilk and harm the baby. Limited human data shows it to be unsafe for nursing mothers.
| Habit Forming | No |
| Chemical Class | Synthetic imidazole derivative |
| Therapeutic Class | CARDIAC |
| Action Class | Angiotensin receptor blockers(ARB) |
₹101.2
₹110
8% OFF
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024
